Review




Structured Review

Mimetics smac mimetics antagonize ciap1 2
Smac Mimetics Antagonize Ciap1 2, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1+2/mimetics+smac/pm41531664-235-0-1
Average 86 stars, based on 1 article reviews
smac mimetics antagonize ciap1 2 - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

other:

Article Title: Reprogramming gut microenvironment for the treatment of acute severe ulcerative colitis via a synergistic therapy of necroptosis blockade and organoid transplantation.
Article Snippet: HeLa cells were treated with 20 ng/ml TNFα, 1 μM Smac mimetics and 20 μM zVAD.

Article Title: Species-specific cleavage of the autophagy adaptor p62 dictates responses to TNF.
Article Snippet: Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.

Article Title: Reprogramming gut microenvironment for the treatment of acute severe ulcerative colitis via a synergistic therapy of necroptosis blockade and organoid transplantation.
Article Snippet: For TSZ stimulation, HT-29 cells and colonic organoids were treated with 10 ng/ml TNFα, 1 μM Smac mimetics and 20 μM zVAD.

Article Title: The Role of Mitochondria in Polycystic Kidney Disease.
Article Snippet: Other studies showed that second mitochondriaderived activator of caspases (Smac) mimetics can induce the death of TNF-α-dependent cystic renal epithelial cell, significantly reducing renal cysts in mouse models [70].

Article Title: Defensin‐DNA Supramolecular Complexes as a New pH‐Sensing Nanomaterial
Article Snippet: Zebrafish embryos were imaged as previously described using an Andor Dragonfly 202 spinning-disk confocal microscope (Andor Technology, Oxford Instruments, Belfast, UK) [ 38 ].

Article Title: PD-1/PD-L1 inhibitors
Article Snippet: In another specific embodiment, a compound disclosed herein, or a pharmaceutically acceptable salt thereof, is combined with an HBV DNA polymerase inhibitor and at least one additional therapeutic agent selected from the group consisting of: immunomodulators, TLR modulators, interferon alpha receptor ligands, hyaluronidase inhibitors, recombinant IL-7, HBsAg inhibitors, HBsAg secretion or assembly inhibitors, compounds targeting HBcAg, cyclophilin inhibitors, HBV vaccines, HBV viral entry inhibitors, NTCP inhibitors, antisense oligonucleotide targeting viral mRNA, siRNA, miRNA gene therapy agents, endonuclease modulators, inhibitors of ribonucleotide reductase, hepatitis B virus E antigen inhibitors, recombinant SRA proteins, src kinase inhibitors, HBx inhibitors, cccDNA inhibitors, sshRNAs, HBV antibodies including HBV antibodies targeting the surface antigens of the hepatitis B virus and bispecific antibodies and “antibody-like” therapeutic proteins (such as DARTs®, DUOBODIES®, BITES®, XmAbs®, TandAbs, Fab derivatives, or TCR-like antibodies), CCR2 chemokine antagonists, thymosin agonists, cytokines, nucleoprotein modulators (HBV core or capsid protein modulators), stimulators of retinoic acid-inducible gene 1, stimulators of RIG-I like receptors, stimulators of NOD2, stimulators of NOD1, Arginase inhibitors, STING agonists, PI3K inhibitors, lymphotoxin beta receptor activators, natural killer cell receptor 2B4 inhibitors, Lymphocyte-activation gene 3 inhibitors, CD160 inhibitors, cytotoxic T-lymphocyte-associated protein 4 (ipi4) inhibitors, CD137 inhibitors, Killer cell lectin-like receptor subfamily G member 1 inhibitors, TIM-3 inhibitors, B- and T-lymphocyte attenuator inhibitors, CD305 inhibitors, PD-1 inhibitors, PD-L1 inhibitors, PEG-Interferon Lambda, recombinant thymosin alpha-1, BTK inhibitors, modulators of TIGIT, modulators of CD47, modulators of SIRPalpha, modulators of ICOS, modulators of CD27, modulators of CD70, modulators of OX40, epigenetic modifiers, modulators of NKG2D, modulators of Tim-4, modulators of B7-H4, modulators of B7-H3, modulators of NKG2A, modulators of GITR, modulators of CD160, modulators of HEVEM, modulators of CD161, modulators of Axl, modulators of Mer, modulators of Tyro, gene modifiers or editors such as CRISPR (including CRISPR Cas9), zinc finger nucleases or synthetic nucleases (TALENs), IAPs inhibitors, SMAC mimetics, KDM5 inhibitors, IDO inhibitors, and hepatitis B virus replication inhibitors.

In Vitro:

Article Title: To Kill a Macrophage: Targeted Strategies to Eliminate Macrophage Reservoirs of HIV
Article Snippet: .. SMAC mimetics LCL161 and birinapant have demonstrated efficacy in vitro in inducing selective apoptosis of HIVinfected MDM from uninfected controls [86] and PWH, regardless of ART status [83]. ..

Inhibition:

Article Title: Ferroptosis, pyroptosis, and necroptosis in melanoma: regulatory cell death pathways and their implications for immunotherapy
Article Snippet: .. Necroptosis , RIPK1/RIPK/MLKL Axis; TNF-α Inhibition; Epigenetic Silencing of RIPK3 , RIPK3; p-MLKL; HMGB1 , 5-Azacytidine; Vorinostat; SMAC Mimetics. ..



Similar Products

86
Mimetics smac mimetics antagonize ciap1 2
Smac Mimetics Antagonize Ciap1 2, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1+2/mimetics+smac/pm41531664-235-0-1
Average 86 stars, based on 1 article reviews
smac mimetics antagonize ciap1 2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

93
R&D Systems anti pan ciap1 2
Anti Pan Ciap1 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1+2/Human%2FMouse+cIAP+Pan-specific+Antibody/pm23323685__cb3005512_si_001-47-3-7
Average 93 stars, based on 1 article reviews
anti pan ciap1 2 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems anti ciap1 goat pab af8181
Anti Ciap1 Goat Pab Af8181, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1+2/Human+cIAP-1%2FHIAP-2+Antibody/pm33603969__ml0c00605_si_001-657-42-46
Average 93 stars, based on 1 article reviews
anti ciap1 goat pab af8181 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
SMAC Corp mimetic dual ciap1/2 and xiap inhibitor
Mimetic Dual Ciap1/2 And Xiap Inhibitor, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1+2/mimetic+dual+ciap1+2+and+xiap+inhibitor/pm39671726-23-61-62
Average 90 stars, based on 1 article reviews
mimetic dual ciap1/2 and xiap inhibitor - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

98
InvivoGen dual ciap1 2
Dual Ciap1 2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1+2/BV6/pm39671726-61-3-9
Average 98 stars, based on 1 article reviews
dual ciap1 2 - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

93
R&D Systems anti ciap1 polyclonal antibody
Anti Ciap1 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1+2/Human+cIAP-1%2FHIAP-2+Antibody/pmc11503241-85-16-19
Average 93 stars, based on 1 article reviews
anti ciap1 polyclonal antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems α ciap1
(A) hMOs were grown for three to seven days in growth medium followed by 24 h treatment with 10 µM of BV6, Birinapant (Bi), ASTX-660 (ASTX) and LCL-161 (LCL), respectively, or DMSO as vehicle control. Subsequently, CellTiter-Glo® viability assays were performed and the values were normalized to non-treated controls. Error bars represent standard deviation. * p < 0.05, ** p< 0.01, *** p < 0.005. (B) hMOs, treated as in (A) were harvested and Western blotting was performed with antibodies recognizing <t>cIAP1,</t> cIAP2, XIAP as well as total and cleaved caspase-3. Vinculin served as loading control. Representative blots of three independent experiments are shown.
α Ciap1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ciap1+2/Human+cIAP-1%2FHIAP-2+Antibody/bio_rxiv__2024__08__28__610103-63-51-53
Average 93 stars, based on 1 article reviews
α ciap1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


(A) hMOs were grown for three to seven days in growth medium followed by 24 h treatment with 10 µM of BV6, Birinapant (Bi), ASTX-660 (ASTX) and LCL-161 (LCL), respectively, or DMSO as vehicle control. Subsequently, CellTiter-Glo® viability assays were performed and the values were normalized to non-treated controls. Error bars represent standard deviation. * p < 0.05, ** p< 0.01, *** p < 0.005. (B) hMOs, treated as in (A) were harvested and Western blotting was performed with antibodies recognizing cIAP1, cIAP2, XIAP as well as total and cleaved caspase-3. Vinculin served as loading control. Representative blots of three independent experiments are shown.

Journal: bioRxiv

Article Title: Inhibition of IAPs induces programmed cell death and inflammatory signaling in patient-derived metastatic breast cancer organoids

doi: 10.1101/2024.08.28.610103

Figure Lengend Snippet: (A) hMOs were grown for three to seven days in growth medium followed by 24 h treatment with 10 µM of BV6, Birinapant (Bi), ASTX-660 (ASTX) and LCL-161 (LCL), respectively, or DMSO as vehicle control. Subsequently, CellTiter-Glo® viability assays were performed and the values were normalized to non-treated controls. Error bars represent standard deviation. * p < 0.05, ** p< 0.01, *** p < 0.005. (B) hMOs, treated as in (A) were harvested and Western blotting was performed with antibodies recognizing cIAP1, cIAP2, XIAP as well as total and cleaved caspase-3. Vinculin served as loading control. Representative blots of three independent experiments are shown.

Article Snippet: The following antibodies were used in this study: α-Vinculin (V9131, Sigma), α-RIPK1 (610459, BD Biosciences), α-phospho-RIPK1 S166 (657465, Cell Signaling Technologies), α-RIPK3 (13526, Cell Signaling Technologies), α-phoshpo-RIPK3 S227 (ab209384, Abcam), α-MLKL (14993, Cell Signaling Technologies), α-phospho-MLKL S358 (91689, Cell Signaling Technologies), α-caspase-3 (9662S, Cell Signaling Technologies), α-cleaved-caspase-3 (9661, Cell Signaling Technologies), α-cIAP1 (AF8181, R&D Systems), α-cIAP2 (3130, Cell Signaling Technologies), α-XIAP (610716, BD Biosciences).

Techniques: Control, Standard Deviation, Western Blot